APA
Tawara K., Scott H., Emathinger J., Ide A., Fox R., Greiner D., LaJoie D., Hedeen D., Nandakumar M., Oler A. J., Holzer R. & Jorcyk C. (2019). Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion. : Translational oncology.
Chicago
Tawara Ken, Scott Hannah, Emathinger Jacqueline, Ide Alex, Fox Ryan, Greiner Daniel, LaJoie Dollie, Hedeen Danielle, Nandakumar Madhuri, Oler Andrew J, Holzer Ryan and Jorcyk Cheryl. 2019. Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion. : Translational oncology.
Harvard
Tawara K., Scott H., Emathinger J., Ide A., Fox R., Greiner D., LaJoie D., Hedeen D., Nandakumar M., Oler A. J., Holzer R. and Jorcyk C. (2019). Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion. : Translational oncology.
MLA
Tawara Ken, Scott Hannah, Emathinger Jacqueline, Ide Alex, Fox Ryan, Greiner Daniel, LaJoie Dollie, Hedeen Danielle, Nandakumar Madhuri, Oler Andrew J, Holzer Ryan and Jorcyk Cheryl. Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion. : Translational oncology. 2019.